Clinical Trial Update: [11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine [Phase 1]

View source ↗

Summary

Phase 1 trial investigating [11C]-(R)-Rolipram to measure cAMP signaling before and after ketamine in depression; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• [11C]R-rolipram (11C-labeled rolipram radiotracer)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 1 | Status: TERMINATED | Results posted: 2024-03-05